Health and Me

Rachel V Thomas

US FDA Launches Expedited IND Pilot To Speed Up Drug Trials

FDA Launches Expedited IND Pilot To Speed Up Drug Trials

The US Food and Drug Administration (FDA) today launched a pilot program aimed at speeding up early-stage drug research and reducing delays before potential new medicines enter human trials.

Called the Expedited Investigational New Drug (IND) Pilot, the program is part of the US Department of Health and Human Services’ (HHS) Operation TrailBlazer, launched in June.

The initiative aligns with the Trump Administration’s efforts to accelerate clinical trials and drug research in the US and maintain American leadership in medical innovation, particularly ahead of China.

“The pilot not only pairs industry innovators with top research institutions to accelerate high-quality data being submitted to the FDA, it also tests if the partnership can accelerate what happens after the FDA allows a clinical trial to proceed,” said Acting FDA Commissioner Kyle Diamantas, J.D.

Also read: <a href="https://www.healthandme.com/health-news/robert-f-kennedy-jr-launches-reforms-to-speed-up-early-drug-research-in-us-article-154732229" data-type="tilCustomLink">Robert F. Kennedy Jr. Launches Reforms To Speed Up Early Drug Research In US</a>

The pilot aims to shorten the time between identifying a potential drug and starting a first-in-human clinical trial by pairing drug companies with qualified research institutions (QRIs).

These institutions will provide scientific expertise to support the preparation of Investigational New Drug (IND) applications.

The FDA said first-in-human clinical trials can currently take up to two years to complete in the US. Similar trials are completed faster in China and Australia, raising concerns about America's position in global scientific innovation.

The FDA will accept applications to participate in the pilot until October 30, 2026.

Under the pilot, selected QRIs will support the IND application preparation process. This will allow the FDA to review and accept individual components of an application on a rolling basis during the pre-IND phase, rather than waiting for all components before beginning review.

The approach is intended to help identify and resolve issues with an IND application sooner and reduce the risk of the FDA placing a first-in-human clinical trial on hold during the 30-day IND period.

Read More: <a href="https://www.healthandme.com/health-news/18-year-old-dies-from-rare-measles-brain-complication-as-pennsylvania-death-toll-hits-4-article-156165421" data-type="tilCustomLink">18-Year-Old Dies From Rare Measles Brain Complication As Pennsylvania Death Toll Hits 4</a>

The FDA said the goal is to make the path from scientific discovery to first-in-human trials faster, more predictable and more collaborative.

The federal agency said earlier planning and coordination could reduce unnecessary delays between the start of IND preparation and the beginning of first-in-human studies.

“The pilot hopes to utilize the American innovation ecosystem to accelerate the time to first-in-human clinical trials,” said Karim Mikhail, Director of the Center for Biologics Evaluation and Research (CBER).

Drug sponsors and prospective QRIs will apply as a pair, with drug sponsors submitting applications to the FDA.

Applications will be reviewed by FDA scientific experts. The agency expects to select 8–10 Sponsor-QRI pairs for the initial pilot cohort.

READ: <a href="https://www.healthandme.com/health-news/fall-vaccines-2026-us-doctors-issue-covid-flu-and-rsv-jab-guidance-article-156034416" data-type="tilCustomLink">Fall Vaccines 2026: US Doctors Issue COVID, Flu And RSV Jab Guidance</a>

While launching Operation TrialBlazer, Robert F. Kennedy Jr., in a Fox News op-ed, said, “America should continue to lead the world in clinical research and medical innovation. Instead, we are losing ground.”

He cited a study showing that China now conducts more early-stage clinical trials than the United States.

In 2025, Chinese companies accounted for nearly half of global pharmaceutical licensing deal activity. “Those trends should concern every American,” Kennedy said, stressing that “the future of medicine should be built in America.”

According to the FDA, Operation TrialBlazer will help shorten development timelines by six to 12 months through a series of measures, including pairing drug developers with qualified academic centers and contract research organizations to prepare first-in-human trial applications.

Health Conditions A-Z

health

fda-launches-expedited-ind-pilot-to-speed-up-drug-trials

Expedited IND Pilot

FDA Launches Expedited IND Pilot

Drug Trials US

Operation TrailBlazer

after-lindsay-clancy-trial-massachusetts-pushes-stronger-postpartum-mental-health-screening

After Lindsay Clancy Trial, Massachusetts Pushes Stronger Postpartum Mental Health Screening

rfk-jr-backed-wolverine-peptide-use-surges-why-are-people-taking-an-unapproved-drug-for-injury-recovery

RFK Jr-Backed ‘Wolverine’ Peptide Use Surges: Why Are People Taking An Unapproved Drug For Injury Recovery?

Health News

8 Sit-Up Variations to Strengthen Your Core and Build Stability

Benefits Of Ayurvedic Health Supplement Ashwagandha

9 Anti-Inflammatory Breakfast Options You Should Try

5 Foods You Should Avoid For PCOS, Says Gynecologist

Love Sitting With Your Legs Crossed? Here’s You Should Avoid It

6 Daily Foods That Are Secretly Increasing Your Calories

9 Brain Boosters You Should Do Everyday

Hip Exercises That Will Keep You Flexible As You Age

9 Leg Exercises Office Workers’ Should Do At Home

Benefits of Having Herbal Tea Every Morning

9 Daily Habits That Boost Your Brain Power

Lower-Body Exercises That Are Game-Changers

How Drinking Apple Cider Vinegar Helps You

Aging Myths You Should Never Believe

Superfoods That Support Your Gut Health

What Happens To Your Body When You Eat Instant Noodles Every Day?

Health Issues Premature Babies Often Face

Exercises Office Workers Should Do For Their Heart Health

Reasons Why You Should Add Raw Turmeric To Your Diet

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

The US Food and Drug Administration (FDA) today launched a pilot program aimed at speeding up early-stage drug research and reducing delays before potential new medicines enter human trials.Called the Expedited Investigational New Drug (IND) Pilot, the program is part of the US Department of Health and Human Services’ (HHS) Operation TrailBlazer, launched in June.The initiative aligns with the Trump Administration’s efforts to accelerate clinical trials and drug research in the US and maintain American leadership in medical innovation, particularly ahead of China.“The pilot not only pairs industry innovators with top research institutions to accelerate high-quality data being submitted to the FDA, it also tests if the partnership can accelerate what happens after the FDA allows a clinical trial to proceed,” said Acting FDA Commissioner Kyle Diamantas, J.D.How Will the Pilot Work?Also read: Robert F. Kennedy Jr. Launches Reforms To Speed Up Early Drug Research In USThe pilot aims to shorten the time between identifying a potential drug and starting a first-in-human clinical trial by pairing drug companies with qualified research institutions (QRIs).These institutions will provide scientific expertise to support the preparation of Investigational New Drug (IND) applications.The FDA said first-in-human clinical trials can currently take up to two years to complete in the US. Similar trials are completed faster in China and Australia, raising concerns about America's position in global scientific innovation.The FDA will accept applications to participate in the pilot until October 30, 2026.Review of IND ApplicationsUnder the pilot, selected QRIs will support the IND application preparation process. This will allow the FDA to review and accept individual components of an application on a rolling basis during the pre-IND phase, rather than waiting for all components before beginning review.The approach is intended to help identify and resolve issues with an IND application sooner and reduce the risk of the FDA placing a first-in-human clinical trial on hold during the 30-day IND period.Read More: 18-Year-Old Dies From Rare Measles Brain Complication As Pennsylvania Death Toll Hits 4The FDA said the goal is to make the path from scientific discovery to first-in-human trials faster, more predictable and more collaborative.The federal agency said earlier planning and coordination could reduce unnecessary delays between the start of IND preparation and the beginning of first-in-human studies.“The pilot hopes to utilize the American innovation ecosystem to accelerate the time to first-in-human clinical trials,” said Karim Mikhail, Director of the Center for Biologics Evaluation and Research (CBER).Who Can Apply?Drug sponsors and prospective QRIs will apply as a pair, with drug sponsors submitting applications to the FDA.Applications will be reviewed by FDA scientific experts. The agency expects to select 8–10 Sponsor-QRI pairs for the initial pilot cohort. READ: Fall Vaccines 2026: US Doctors Issue COVID, Flu And RSV Jab GuidanceWhat Is Operation TrialBlazer?While launching Operation TrialBlazer, Robert F. Kennedy Jr., in a Fox News op-ed, said, “America should continue to lead the world in clinical research and medical innovation. Instead, we are losing ground.”He cited a study showing that China now conducts more early-stage clinical trials than the United States.In 2025, Chinese companies accounted for nearly half of global pharmaceutical licensing deal activity. “Those trends should concern every American,” Kennedy said, stressing that “the future of medicine should be built in America.”According to the FDA, Operation TrialBlazer will help shorten development timelines by six to 12 months through a series of measures, including pairing drug developers with qualified academic centers and contract research organizations to prepare first-in-human trial applications.

fda launches expedited ind pilot to speed up drug trials

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

US FDA Launches Expedited IND Pilot To Speed Up Drug Trials

RFK Jr-Backed ‘Wolverine’ Peptide Use Surges: Why Are People Taking An Unapproved Drug For Injury Recovery?

18-Year-Old Dies From Rare Measles Brain Complication As Pennsylvania Death Toll Hits 4

Bouncy Castles Linked To MRSA Outbreak In 48 Children In Ireland

Health Conditions A-Z